Calamos Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.8M Sell
422,940
-10,593
-2% -$946K 0.15% 146
2026
Q1
$31.1M Buy
433,533
+8,850
+2% +$682K 0.11% 206
2025
Q4
$33.7M Buy
424,683
+204,165
+93% +$16.1M 0.13% 180
2025
Q3
$16.6M Hold
220,518
0.06% 310
2025
Q2
$15.2M Hold
220,518
0.06% 317
2025
Q1
$14.9M Buy
220,518
+2,451
+1% +$147K 0.07% 311
2024
Q4
$9.79M Hold
218,067
0.04% 395
2024
Q3
$13.7M Sell
218,067
-5,339
-2% -$311K 0.06% 344
2024
Q2
$13.2M Sell
223,406
-8,137
-4% -$509K 0.06% 340
2024
Q1
$18.5M Sell
231,543
-6,011
-3% -$459K 0.09% 262
2023
Q4
$18.8M Sell
237,554
-4,732
-2% -$337K 0.09% 264
2023
Q3
$16.9M Hold
242,286
0.09% 280
2023
Q2
$16.7M Sell
242,286
-26,853
-10% -$1.91M 0.08% 296
2023
Q1
$20M Sell
269,139
-30,000
-10% -$2.52M 0.1% 261
2022
Q4
$27.9M Sell
299,139
-47,838
-14% -$4.62M 0.13% 200
2022
Q3
$33.1M Sell
346,977
-181
-0.1% -$17.9K 0.15% 168
2022
Q2
$32.2M Buy
347,158
+8,628
+3% +$842K 0.14% 174
2022
Q1
$34.3M Buy
338,530
+42,010
+14% +$4.41M 0.13% 189
2021
Q4
$30.6M Buy
296,520
+10,087
+4% +$932K 0.11% 210
2021
Q3
$24.3M Buy
286,433
+24,032
+9% +$2.01M 0.11% 218
2021
Q2
$21.9M Buy
262,401
+53,654
+26% +$4.39M 0.1% 227
2021
Q1
$15.7M Buy
208,747
+5,509
+3% +$401K 0.09% 248
2020
Q4
$13.9M Sell
203,238
-7,334
-3% -$477K 0.08% 267
2020
Q3
$12.3M Sell
210,572
-16,100
-7% -$1M 0.08% 259
2020
Q2
$14.7M Sell
226,672
-12,607
-5% -$794K 0.1% 224
2020
Q1
$14.2M Sell
239,279
-22,114
-8% -$1.48M 0.11% 217
2019
Q4
$19.4M Sell
261,393
-1,748
-0.7% -$123K 0.1% 238
2019
Q3
$16.6M Buy
263,141
+22,461
+9% +$1.33M 0.09% 259
2019
Q2
$13.1M Sell
240,680
-11,223
-4% -$604K 0.07% 294
2019
Q1
$13.6M Sell
251,903
-1,886
-0.7% -$116K 0.08% 270
2018
Q4
$16.6M Buy
253,789
+94,510
+59% +$7.05M 0.11% 232
2018
Q3
$12.5M Buy
159,279
+5,675
+4% +$406K 0.07% 286
2018
Q2
$9.88M Buy
153,604
+1,710
+1% +$113K 0.06% 323
2018
Q1
$9.45M Buy
151,894
+7,123
+5% +$511K 0.06% 327
2017
Q4
$10.5M Sell
144,771
-5,345
-4% -$389K 0.05% 287
2017
Q3
$12.2M Buy
150,116
+5,377
+4% +$425K 0.09% 247
2017
Q2
$11.6M Sell
144,739
-15,086
-9% -$1.19M 0.09% 270
2017
Q1
$12.5M Sell
159,825
-547
-0.3% -$43.7K 0.1% 252
2016
Q4
$12.7M Sell
160,372
-3,291
-2% -$266K 0.1% 232
2016
Q3
$14.6M Buy
163,663
+157
+0.1% +$14.8K 0.1% 229
2016
Q2
$15.7M Buy
163,506
+60
+0% +$5.98K 0.11% 221
2016
Q1
$17M Buy
163,446
+9,901
+6% +$963K 0.11% 205
2015
Q4
$15M Hold
153,545
0.1% 229
2015
Q3
$14.8M Sell
153,545
-6,048
-4% -$636K 0.1% 219
2015
Q2
$16.7M Sell
159,593
-5,915
-4% -$604K 0.1% 214
2015
Q1
$17.1M Buy
165,508
+8,493
+5% +$859K 0.11% 205
2014
Q4
$15.1M Buy
157,015
+815
+0.5% +$71.8K 0.1% 217
2014
Q3
$12.4M Hold
156,200
0.08% 234
2014
Q2
$11.8M Buy
156,200
+11,200
+8% +$846K 0.07% 233
2014
Q1
$10.9M Hold
145,000
0.07% 238
2013
Q4
$10.4M Buy
145,000
+40,000
+38% +$2.57M 0.07% 241
2013
Q3
$5.96M Sell
105,000
-40,000
-28% -$2.38M 0.04% 285
2013
Q2
$8.29M Buy
+145,000
New +$8.4M 0.05% 238

Other funds holding CVS

Calamos Advisors's CVS Position: Q2 2026 in Review

Calamos Advisors reduced its CVS Health (CVS) stake by 2.4% in Q2 2026, selling an estimated $946K and leaving 422,940 shares worth $43.8M. The position accounts for 0.15% of the portfolio, ranked #146.

Calamos Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Calamos Advisors held 422,940 shares of CVS Health worth $43.8M as of Q2 2026.
  • Calamos Advisors sold 10,593 CVS Health shares in Q2 2026, an estimated $946K.
  • CVS Health made up 0.15% of Calamos Advisors's portfolio in Q2 2026, its #146 holding.
  • Calamos Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.